Last reviewed · How we verify
Cortexone — Competitive Intelligence Brief
unknown
desoxycortone
Corticosteroid-binding globulin, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2A
Hematology
Live · refreshed every 30 min
Target snapshot
Cortexone (desoxycortone). Cortexone works by binding to the mineralocorticoid receptor, mimicking the effects of naturally occurring corticosteroids.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cortexone TARGET | desoxycortone | unknown | desoxycortone | Corticosteroid-binding globulin, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2A |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (desoxycortone class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cortexone CI watch — RSS
- Cortexone CI watch — Atom
- Cortexone CI watch — JSON
- Cortexone alone — RSS
- Whole desoxycortone class — RSS
Cite this brief
Drug Landscape (2026). Cortexone — Competitive Intelligence Brief. https://druglandscape.com/ci/desoxycortone. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing